MedPath

A Strategy for Gallstone Expulsion Through Dietary Therapy

Not Applicable
Recruiting
Conditions
Gallbladder Stone
Interventions
Drug: Functional fatty acids
Other: Placebo
Registration Number
NCT06699030
Lead Sponsor
Hepatopancreatobiliary Surgery Institute of Gansu Province
Brief Summary

This study is a double-blind, prospective, single-center controlled trial conducted at a tertiary hospital, aiming to determine whether dietary therapy can effectively expel gallstones.

Detailed Description

Gallstones are a common clinical condition, and their prevalence has been increasing globally in recent years. Gallstone formation is a result of various combined factors, and in its early stages, gallstones often exist in a sludge-like form. Currently, there is no definitive research on whether gallbladder sludge can be effectively expelled through medication or dietary therapy. Therefore, the investigators are conducting a double-blind, prospective, single-center controlled trial to verify whether gallbladder sludge-like stones can be effectively expelled using dietary therapy.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
100
Inclusion Criteria
  • Gallbladder sludge-like stones with a maximum stone diameter of less than 2 mm
Exclusion Criteria
  • History of ERCP (Endoscopic Retrograde Cholangiopancreatography)
  • Previous gallstone removal surgery with gallbladder preservation
  • History of acute or chronic pancreatitis, cholangitis
  • Mirizzi Syndrome
  • History of gastrointestinal surgery
  • Gastrointestinal obstruction
  • Dysfunction of the sphincter of Oddi
  • Gallbladder neck polyps
  • Abnormal gallbladder structure
  • Gallbladder mass
  • Biliary infection or stones
  • Congenital biliary abnormalities
  • Biliary injury or surgery
  • Biliary tumors
  • Gastrointestinal bleeding, liver cirrhosis, or other malignant diseases
  • Significant arrhythmia, bradycardia, or atrioventricular block
  • Severe hypertension, liver or kidney insufficiency
  • Immune, endocrine, hematological, or mental disorders
  • Severe cerebrovascular disease
  • Allergy to relevant foods
  • Pregnant or breastfeeding women
  • Unwillingness or inability to consent to participation

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Functional fatty acidsFunctional fatty acidsOral Administration of functional fatty acids
PlaceboPlaceboOral Administration of Placebo
Primary Outcome Measures
NameTimeMethod
Number of patients with complete expulsion of gallbladder sludge after three days of intervention7 days

Determined by ultrasound examination before and after the intervention to assess whether gallbladder sludge has been fully expelled

2)Number of patients with complete expulsion of gallbladder sludge after six days of intervention7 days

Determined by ultrasound examination before and after the intervention to assess whether gallbladder sludge has been fully expelled

Secondary Outcome Measures
NameTimeMethod
Occurrence of Gastrointestinal Bleeding Post-Intervention14 days

Black stool or decrease of HB

Nausea, Vomiting, and Diarrhea Post-Intervention14 days

Frequency of Nausea, Vomiting, and Diarrhea Post-Intervention

Gallbladder Volume7 days

Measured by ultrasound (L × W × D × 0.52)

Gallbladder Wall Thickness7 days

Measured by ultrasound, accurate to 0.1 mm

Serum bilirubin7 days

Determined by lab examination within 3.4-17.1μmol/L

Presence of Abdominal Pain Post-Intervention7 days

If abdominal pain is present, it will be assessed using the Numerical Rating Scale (NRS) within 0-10, The higher the score, the more serious it is

Occurrence of Acute Pancreatitis Post-Intervention14 days

Pain and Amy \>3times as normal

Trial Locations

Locations (1)

Long Deng

🇨🇳

Lanzhou, Gansu, China

© Copyright 2025. All Rights Reserved by MedPath